JP2013525454A5 - - Google Patents

Download PDF

Info

Publication number
JP2013525454A5
JP2013525454A5 JP2013508243A JP2013508243A JP2013525454A5 JP 2013525454 A5 JP2013525454 A5 JP 2013525454A5 JP 2013508243 A JP2013508243 A JP 2013508243A JP 2013508243 A JP2013508243 A JP 2013508243A JP 2013525454 A5 JP2013525454 A5 JP 2013525454A5
Authority
JP
Japan
Prior art keywords
fluoro
salt
prepare
mixing
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013508243A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013525454A (ja
JP5865898B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/034278 external-priority patent/WO2011137222A1/en
Publication of JP2013525454A publication Critical patent/JP2013525454A/ja
Publication of JP2013525454A5 publication Critical patent/JP2013525454A5/ja
Application granted granted Critical
Publication of JP5865898B2 publication Critical patent/JP5865898B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013508243A 2010-04-30 2011-04-28 リネゾリドを調製するためのプロセス Expired - Fee Related JP5865898B2 (ja)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US32989210P 2010-04-30 2010-04-30
US61/329,892 2010-04-30
US35985110P 2010-06-30 2010-06-30
US61/359,851 2010-06-30
US37557610P 2010-08-20 2010-08-20
US61/375,576 2010-08-20
US38953410P 2010-10-04 2010-10-04
US61/389,534 2010-10-04
US42144210P 2010-12-09 2010-12-09
US61/421,442 2010-12-09
PCT/US2011/034278 WO2011137222A1 (en) 2010-04-30 2011-04-28 Processes for preparing linezolid

Publications (3)

Publication Number Publication Date
JP2013525454A JP2013525454A (ja) 2013-06-20
JP2013525454A5 true JP2013525454A5 (cg-RX-API-DMAC7.html) 2014-06-19
JP5865898B2 JP5865898B2 (ja) 2016-02-17

Family

ID=44861911

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013508243A Expired - Fee Related JP5865898B2 (ja) 2010-04-30 2011-04-28 リネゾリドを調製するためのプロセス

Country Status (15)

Country Link
US (2) US9206141B2 (cg-RX-API-DMAC7.html)
EP (2) EP2899185B1 (cg-RX-API-DMAC7.html)
JP (1) JP5865898B2 (cg-RX-API-DMAC7.html)
KR (1) KR20130108975A (cg-RX-API-DMAC7.html)
CN (1) CN103025730A (cg-RX-API-DMAC7.html)
AU (1) AU2011245302A1 (cg-RX-API-DMAC7.html)
BR (1) BR112012027901A2 (cg-RX-API-DMAC7.html)
CA (1) CA2798101A1 (cg-RX-API-DMAC7.html)
IL (1) IL222770A0 (cg-RX-API-DMAC7.html)
MX (1) MX2012012627A (cg-RX-API-DMAC7.html)
RU (1) RU2012151303A (cg-RX-API-DMAC7.html)
SG (1) SG185103A1 (cg-RX-API-DMAC7.html)
TW (1) TWI535715B (cg-RX-API-DMAC7.html)
WO (1) WO2011137222A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201208382B (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103025730A (zh) * 2010-04-30 2013-04-03 印第安纳大学研究及科技有限公司 制备利奈唑胺的方法
EP2595968B1 (en) 2011-02-24 2015-09-09 Lee Pharma Limited Novel process for preparation of linezolid and its novel intermediates
WO2013072923A1 (en) * 2011-09-19 2013-05-23 Cadila Healthcare Limited Process for the preparation of crystalline linezolid
CN103254148B (zh) * 2012-02-15 2016-04-13 浙江海正药业股份有限公司 利奈唑胺中间体的制备方法
CN103288814B (zh) * 2012-02-24 2016-07-06 国药集团国瑞药业有限公司 一种利伐沙班中间体的制备方法
EP2834235A1 (en) 2012-04-06 2015-02-11 Indiana University Research and Technology Corporation Processes for preparing rivaroxaban
ITMI20120655A1 (it) * 2012-04-19 2013-10-20 Bioindustria Lab Italiano M Edicinali Spa Procedimento per la preparazione di linezolid
AR090844A1 (es) * 2012-04-27 2014-12-10 Actelion Pharmaceuticals Ltd Proceso para elaborar derivados de naftiridina
CN103626712B (zh) * 2012-08-23 2016-06-01 重庆药友制药有限责任公司 一种用于制备利奈唑胺的中间体及其制备方法
WO2014045292A1 (en) * 2012-09-20 2014-03-27 Symed Labs Limited Improved process for the preparation of linezolid intermediate
WO2014170908A1 (en) * 2013-04-18 2014-10-23 Nosch Labs Private Limited Process for preparation of oxazolidinone derivatives
EP3250568A4 (en) * 2016-04-21 2018-08-01 Optimus Drugs Pvt Ltd An improved process for the preparation of linezolid
CN110194750A (zh) * 2019-06-19 2019-09-03 四川美大康华康药业有限公司 一种利奈唑胺的制备方法及精制方法
CN112159368A (zh) * 2020-07-07 2021-01-01 杭州杜易科技有限公司 一种利奈唑胺中间体的合成方法
RU2760198C1 (ru) * 2020-12-16 2021-11-22 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Однореакторный способ получения полупродукта для синтеза линезолида
CN115684399B (zh) * 2022-10-27 2024-12-20 贵州健安德科技有限公司 一种氯醇亚胺的高效液相检测及含量测定方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3725450A (en) * 1970-10-05 1973-04-03 Gen Mills Chem Inc Process for the preparation of isocyanates from acyl azides
US4937331A (en) 1988-03-25 1990-06-26 President And Fellows Of Harvard College Chiral azetidinone epoxides
DE4119611A1 (de) * 1991-06-14 1992-12-17 Bayer Ag Mittel zur bekaempfung von schaedlingen auf basis substituierter oxazolidinone, neue substituierte oxazolidinone, deren herstellung und verwendung
TW380137B (en) * 1994-03-04 2000-01-21 Merck & Co Inc Process for making an epoxide
DE19542148A1 (de) * 1995-11-11 1997-05-15 Hoechst Ag Verfahren zur Herstellung von fluorierten Aromaten
NZ504372A (en) 1997-11-07 2002-12-20 Upjohn Co Process to produce N-[3-fluoro-4(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinones
US6921825B2 (en) 1998-09-16 2005-07-26 King Pharmaceuticuals Research & Development, Inc. Adenosine A3 receptor modulators
US6444813B2 (en) * 2000-02-02 2002-09-03 Pharmacia & Upjohn Company Linezolid-crystal form II
AR027261A1 (es) 2000-02-02 2003-03-19 Upjohn Co Linezolid forma cristalina ii
SE0001866D0 (sv) * 2000-05-18 2000-05-18 Astrazeneca Ab A new process
ATE321024T1 (de) 2000-10-17 2006-04-15 Pharmacia & Upjohn Co Llc Verfahren zur herstellung von oxazolidinonverbindungen
ATE338035T1 (de) 2001-06-05 2006-09-15 Boehringer Ingelheim Pharma 1,4-disubstituierte benzokondensierte cycloalkyl harnstoffverbindungen
ES2294494T3 (es) 2004-04-19 2008-04-01 Symed Labs Limited Un nuevo procedimiento para la preparacion de linezolid y compuestos relacionados.
EP1768967B1 (en) 2004-07-20 2009-04-22 Symed Labs Limited Novel intermediates for linezolid and related compounds
WO2006091731A2 (en) 2005-02-24 2006-08-31 Teva Pharmaceutical Industries Ltd. Processes for the preparation of linezolid intermediate
WO2007011684A2 (en) 2005-07-15 2007-01-25 Cyclics Corporation Macrocyclic polyester oligomers as carriers and/or flow modifier additives for thermoplastics
AU2007235635A1 (en) 2006-04-07 2007-10-18 Pfizer Products Inc. Process for preparing linezolid
CN101220001A (zh) 2008-01-25 2008-07-16 浙江博泰化工有限公司 一种利奈唑酮的合成方法
CN101638392B (zh) 2009-08-24 2012-05-16 浙江工业大学 一种列奈唑酮的制备方法
CN103025730A (zh) * 2010-04-30 2013-04-03 印第安纳大学研究及科技有限公司 制备利奈唑胺的方法

Similar Documents

Publication Publication Date Title
RU2012151303A (ru) Способы получения линезолида
JP2011105732A5 (cg-RX-API-DMAC7.html)
PE20140826A1 (es) Compuestos sustituidos fungicidas de 2-[2-halogenalquil-4-(fenoxi)-fenil]-1-[1,2,4]triazol-1-il-etanol
JP2012533546A5 (cg-RX-API-DMAC7.html)
JP2011529054A5 (cg-RX-API-DMAC7.html)
JP2009519226A5 (cg-RX-API-DMAC7.html)
JP2012524656A5 (cg-RX-API-DMAC7.html)
JP2013537203A5 (cg-RX-API-DMAC7.html)
JP2010536766A5 (cg-RX-API-DMAC7.html)
JP2011519854A5 (cg-RX-API-DMAC7.html)
PE20140381A1 (es) Dispersiones solidas extruidas por fusion que contienen un agente inductor de apoptosis
JP2009530489A5 (cg-RX-API-DMAC7.html)
JP2015180703A5 (cg-RX-API-DMAC7.html)
JP2012505872A5 (cg-RX-API-DMAC7.html)
JP2010523692A5 (cg-RX-API-DMAC7.html)
JP2010501474A5 (cg-RX-API-DMAC7.html)
JP2017517538A5 (cg-RX-API-DMAC7.html)
AR046942A1 (es) Arilpirazoles sustituidos, un procedimiento para su preparacion, composiciones farmaceuticas o veterinarias que los contienen como principio activo y su uso en la fabricacion de un medicamento parasiticida humano o animal.
PE20110665A1 (es) Compuestos derivados de n-cichohexil-3-(fenilamino)-isonicotinamida como inhibidores de mek
JP2009519903A5 (cg-RX-API-DMAC7.html)
PE20081395A1 (es) Derivados de aril sulfamida y metodos para su uso
JP2014518212A5 (ja) 化合物及び組成物
JP2016535039A5 (cg-RX-API-DMAC7.html)
JP2019501948A5 (cg-RX-API-DMAC7.html)
JP2011190277A5 (cg-RX-API-DMAC7.html)